Sabby Management’s Sonoma Pharmaceuticals SNOA Stock Holding History

Sabby Management’s Portfolio SNOA Stock Details SNOA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-2,583	Closed	-$331K	–	121
2018 Q4	$331K	Buy	+2,583	New	+$515K	0.07%	62
2018 Q2	–	Sell	-384	Closed	-$255K	–	181
2018 Q1	$255K	Buy	+384	New	+$316K	0.03%	115
2015 Q2	–	Sell	-465	Closed	-$352K	–	356
2015 Q1	$352K	Buy	+465	New	+$395K	0.01%	248

Other funds holding SNOA

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Mercer Global Advisors Denver, Colorado $67.6B AUM 18.3% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Sabby Management's SNOA Position: Q1 2019 in Review

Sabby Management sold out of Sonoma Pharmaceuticals (SNOA) in Q1 2019, closing a stake of 2,583 shares — an estimated $331K sold.

Sabby Management first reported a position in SNOA in Q1 2015 and held it in 3 quarters. The position peaked at $352K in Q1 2015. 22 funds tracked by Wall St. Rank hold SNOA as of Q1 2019.

Sabby Management reported no remaining Sonoma Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
Sabby Management sold 2,583 Sonoma Pharmaceuticals shares in Q1 2019, an estimated $331K.
Sabby Management first reported a position in Sonoma Pharmaceuticals in Q1 2015 and held it in 3 quarters.
Sabby Management's Sonoma Pharmaceuticals position peaked at $352K in Q1 2015.
22 funds tracked by Wall St. Rank held Sonoma Pharmaceuticals as of Q1 2019.

Based on Sabby Management's 13F filing for Q1 2019, filed 15 May 2019.